Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.
BACKGROUND: Zoledronic acid is widely used as adjuvant chemotherapy for the treatment of breast cancer. However, previous trials reported inconsistent findings regarding their clinical efficacy and safety. We carried out a comprehensive systematic review and meta-analysis to evaluate the effects of...
Main Authors: | Wei-Wei Huang, Cheng Huang, Jian Liu, Hong-Yu Zheng, Lin Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3406041?pdf=render |
Similar Items
-
Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis
by: Yang Tao, et al.
Published: (2011-08-01) -
Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
by: El Saghir Nagi S, et al.
Published: (2005-12-01) -
Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
by: Neelima Vidula, et al.
Published: (2021-09-01) -
Zoledronic acid in breast cancer: latest findings and interpretations
by: Michael Gnant
Published: (2011-11-01) -
The evolving role of zoledronic acid in early breast cancer
by: Michael Gnant
Published: (2009-04-01)